Home › NDC Lookup › RxCUI directory › RxCUI 314234

Sucralfate 1000 MG Oral Tablet — RxCUI 314234

RxNorm drug concept · Semantic clinical drug
RxCUI 314234 Semantic clinical drug · SCD ● Current RxNorm concept 46 FDA products 105 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI314234
Official nameSucralfate 1000 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assucralfate 1 GM Oral Tablet
FDA products mapped46
Package NDCs mapped105
Reported Medicaid activity (SDUD)559,991 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sucralfate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Sucralfate helps heal a duodenal ulcer — that's an ulcer in the first part of your small intestine. It works by coating the ulcer like a protective bandage, shielding it from stoma...
  • What exactly is sucralfate supposed to do for me?
  • Yes, timing really does matter. You should take sucralfate on an empty stomach so it can stick directly to the ulcer lining. Taking it with food can get in the way of that. If you...
  • When should I take sucralfate — does it matter if I take it with food?
📖 Read our full Sucralfate guide →

🕸️ Concept Web — How Sucralfate 1000 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Sucralfate 1000 MG Oral Tablet RxCUI 314234

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sucralfate 10156
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Carafate 227743
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sucralfate Oral Tablet 373967
    • Sucralfate Oral Product 1161768
    • Sucralfate Pill 1161769
    • Sucralfate Oral Tablet [Carafate] 369284
    • Carafate Oral Product 1173682
    • Carafate Pill 1173683
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sucralfate 1000 MG SCDC · 317509
  • Sucralfate Oral Tablet SCDF · 373967
  • Sucralfate Oral Product SCDG · 1161768
  • Sucralfate Pill SCDG · 1161769

Brand-Name Concepts

  • Sucralfate 1000 MG Oral Tablet [Carafate] SBD · 208097
  • Sucralfate 1000 MG [Carafate] SBDC · 568825
  • Sucralfate Oral Tablet [Carafate] SBDF · 369284
  • Carafate Oral Product SBDG · 1173682
  • Carafate Pill SBDG · 1173683
  • Carafate BN · 227743

📦 FDA Products & Package NDCs

46 products · 105 package NDCs
105 package NDCs map to RxCUI 314234 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
87063-0176-05 500 TABLET in 1 BOTTLE (87063-176-05) Sucralfate ASCLEMED USA INC. 2026-05-18
87063-0176-12 120 TABLET in 1 BOTTLE (87063-176-12) Sucralfate ASCLEMED USA INC. 2026-05-18
87063-0176-30 30 TABLET in 1 BOTTLE (87063-176-30) Sucralfate ASCLEMED USA INC. 2026-05-18
87063-0176-60 60 TABLET in 1 BOTTLE (87063-176-60) Sucralfate ASCLEMED USA INC. 2026-05-18
87063-0176-90 90 TABLET in 1 BOTTLE (87063-176-90) Sucralfate ASCLEMED USA INC. 2026-05-18
Observed labelers: Bryant Ranch Prepack (40) · Aphena Pharma Solutions - Tennessee, LLC (6) · ASCLEMED USA INC. (6) · Amneal Pharmaceuticals NY LLC (4) · Preferred Pharmaceuticals Inc. (4) · Proficient Rx LP (4) · +24 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$0.1830
Range $0.1830–$4.7395 · middle 50% $0.1830–$0.1830 · 13 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.